For instance, PARP inhibitors combined with chemotherapy (TMZ [36], platinum salts [37], gemcitabine [38], etc.)or targeted drugs (EGFR inhibitors [39], HSP90 inhibitors [40], etc.)exert therapeutic effects on malignant tumors. This evidence concerns the gene EGFR and cancer.